Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer
Clinical trial NCT04965714 · WITHDRAWN
Trial details
- NCT number
- NCT04965714
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2023-02-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.